Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Yaziji

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Pathology|August 15, 2000
Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinomaH A Lehr, A Folpe, H Yaziji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring systemT W Jacobs, A M Gown, H Yaziji, et al.
The Histochemical Journal|March 1, 1996
Localization of tartrate-resistant acid phosphatase in human placentaA J Janckila, H Yaziji, S C Lear, et al.
Southern Medical Journal|March 1, 1997
Gestational herpes simplex virus hepatitisH Yaziji, T Hill, T C Pitman, et al.
American Journal of Clinical Pathology|February 9, 2000
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreementT W Jacobs, A M Gown, H Yaziji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancerT W Jacobs, A M Gown, H Yaziji, et al.
American Journal of Clinical Pathology|October 1, 1995
Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissuesH Yaziji, A J Janckila, S C Lear, et al.
American Journal of Clinical Pathology|June 8, 2001
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysisH A Lehr, T W Jacobs, H Yaziji, et al.
American Journal of Clinical Pathology|April 11, 2001
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesionsN S Goldstein, D Bassi, J C Watts, et al.
The American Journal of Surgical Pathology|September 1, 1996
Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesionsH Yaziji, R Massarani-Wafai, M Gujrati, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Pathology|August 15, 2000
Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinomaH A Lehr, A Folpe, H Yaziji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring systemT W Jacobs, A M Gown, H Yaziji, et al.
The Histochemical Journal|March 1, 1996
Localization of tartrate-resistant acid phosphatase in human placentaA J Janckila, H Yaziji, S C Lear, et al.
Southern Medical Journal|March 1, 1997
Gestational herpes simplex virus hepatitisH Yaziji, T Hill, T C Pitman, et al.
American Journal of Clinical Pathology|February 9, 2000
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreementT W Jacobs, A M Gown, H Yaziji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancerT W Jacobs, A M Gown, H Yaziji, et al.
American Journal of Clinical Pathology|October 1, 1995
Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissuesH Yaziji, A J Janckila, S C Lear, et al.
American Journal of Clinical Pathology|June 8, 2001
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysisH A Lehr, T W Jacobs, H Yaziji, et al.
American Journal of Clinical Pathology|April 11, 2001
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesionsN S Goldstein, D Bassi, J C Watts, et al.
The American Journal of Surgical Pathology|September 1, 1996
Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesionsH Yaziji, R Massarani-Wafai, M Gujrati, et al.
Pageof 3